Last reviewed · How we verify

pyrethrins

unknown active ✓ Verified May 2026

pyrethrins is a drug. It is currently in unknown development for Infestation by Phthirus pubis, Pediculosis capitis, Pediculosis corporis.

Pyrethrins are a class of organic compounds derived from Chrysanthemum cinerariifolium that have potent insecticidal activity by disrupting the nervous systems of insects. They are used to prevent and treat conditions such as malaria, trachoma, pediculosis, and head lice, and are classified as a blocker of the voltage-sensitive sodium channel alpha-subunit.

At a glance

Generic namepyrethrins
Therapeutic areaOther
Phaseunknown

Approved indications

Common side effects

No common side effects on file.

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about pyrethrins

What is pyrethrins?

pyrethrins is a pharmaceutical drug, indicated for Infestation by Phthirus pubis, Pediculosis capitis, Pediculosis corporis.

What is pyrethrins used for?

pyrethrins is indicated for Infestation by Phthirus pubis, Pediculosis capitis, Pediculosis corporis.

What development phase is pyrethrins in?

pyrethrins is in unknown.

Related

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing